<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2020-01-02">
  <drugbank-id primary="true">DB11104</drugbank-id>
  <name>Sulfur hexafluoride</name>
  <description>Sulfur hexafluoride is an ultrasound contrast agent indicated for use &#13;
•in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms &#13;
•in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients</description>
  <cas-number>2551-62-4</cas-number>
  <unii>WS7LR3I1D6</unii>
  <average-mass>146.05</average-mass>
  <monoisotopic-mass>145.962490152</monoisotopic-mass>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links>
      <link>
        <ref-id>L675</ref-id>
        <title>FDA label</title>
        <url>https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203684s001lbl.pdf</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Echocardiography: Sulfur hexafluoride is indicated for use in adult patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricularendocardial border. &#13;
Ultrasonography of the Liver: Sulfur hexafluoride is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions.</indication>
  <pharmacodynamics>Sulfur hexafluoride provides useful echocardiographic signal intensity for two minutes after the injection. Sulfur hexafluoride microspheres are destroyed and contrast enhancement decreases as the mechanical index increases (values of 0.8 or less are recommended). &#13;
For ultrasonography of the liver, Sulfur hexafluoride provides dynamic patterns of differential signal intensity enhancement between focal liver lesions and liver parenchyma during the arterial, portal venous, and late phase of signal intensity enhancement of the microvasculature. </pharmacodynamics>
  <mechanism-of-action>Within the blood, the acoustic impedance of Lumason microspheres is lower than that of the surrounding non-aqueous tissue.  Therefore, an ultrasound beam is reflected from the interface between the microspheres and the surrounding tissue. The reflected ultrasound signal provides a visual image that shows a contrast between the blood and the surrounding tissues. </mechanism-of-action>
  <toxicity/>
  <metabolism>SF6 undergoes little or no biotransformation; 88% of an administered dose is recovered unchanged in expired air. </metabolism>
  <absorption>The pharmacokinetic of the SF6 gas component of Lumason was evaluated in 12 healthy adult subjects (7 men and 5 women).  After intravenous bolus injections of 0.03 mL/kg and 0.3 mL/kg of Lumason, corresponding to approximately 1 and 10 times the recommended doses, concentrations of SF6 in blood peaked within 1 to 2 minutes for both doses. </absorption>
  <half-life>The terminal half-life of SF6 in blood was approximately 10 minutes for the 0.3 mL/kg dose. (At the 0.03 mL/kg dose, terminal half-life could not be estimated.) </half-life>
  <protein-binding/>
  <route-of-elimination>The SF6 component of Lumason is eliminated via the lungs. </route-of-elimination>
  <volume-of-distribution>In a study of healthy subjects, the mean values for the apparent steady-state volume of distribution of SF6 were 341 L and 710 L for Lumason doses of 0.03 mL/kg and 0.3 mL/kg, respectively.  Preferential distribution to the lung is likely responsible for these values. </volume-of-distribution>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of inorganic compounds known as other non-metal halides. These are inorganic compounds containing 'other non-metals' and halogen.</description>
    <direct-parent>Other non-metal halides</direct-parent>
    <kingdom>Inorganic compounds</kingdom>
    <superclass>Homogeneous non-metal compounds</superclass>
    <class>Other non-metal halides</class>
    <subclass/>
    <substituent>Other non-metal halide</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="iupac">hexafluoridosulfur</synonym>
    <synonym language="english" coder="">Sulfur fluoride</synonym>
    <synonym language="english" coder="usan">Sulfur hexafluoride</synonym>
    <synonym language="english" coder="iupac">sulfur(6+) fluoride</synonym>
    <synonym language="english" coder="">sulfur(VI) fluoride</synonym>
    <synonym language="english" coder="">Sulphur hexafluoride</synonym>
  </synonyms>
  <products>
    <product>
      <name>LumaSon</name>
      <labeller>Bracco Suisse SA</labeller>
      <ndc-id/>
      <ndc-product-code>68155-099</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Intravenous; Intravesical</route>
      <fda-application-number>NDA203684</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>LumaSon</name>
      <labeller>Bracco Diagnostics Inc</labeller>
      <ndc-id/>
      <ndc-product-code>0270-7099</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form/>
      <strength/>
      <route>Intravenous; Intravesical</route>
      <fda-application-number>NDA203684</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sonovue</name>
      <labeller>Bracco International B.V.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id/>
      <ema-product-code>EMEA/H/C/000303</ema-product-code>
      <ema-ma-number>EU/1/01/177/002</ema-ma-number>
      <started-marketing-on>2001-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, powder, for solution</dosage-form>
      <strength>8 μl/ml</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>EU</country>
      <source>EMA</source>
    </product>
    <product>
      <name>Sonovue</name>
      <labeller>Bracco Imaging S.P.A.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02287684</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-09-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Sonovue</name>
      <ingredients>Sulfur hexafluoride</ingredients>
    </mixture>
    <mixture>
      <name>LumaSon</name>
      <ingredients>1,2-Distearoyllecithin + Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) + Sulfur hexafluoride</ingredients>
    </mixture>
    <mixture>
      <name>LumaSon</name>
      <ingredients>1,2-Distearoyllecithin + Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) + Sulfur hexafluoride</ingredients>
    </mixture>
    <mixture>
      <name>Sonovue</name>
      <ingredients>Sulfur hexafluoride</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids</category>
      <mesh-id>D000143</mesh-id>
    </category>
    <category>
      <category>Acids, Noncarboxylic</category>
      <mesh-id>D000148</mesh-id>
    </category>
    <category>
      <category>Anions</category>
      <mesh-id>D000838</mesh-id>
    </category>
    <category>
      <category>Contrast Media</category>
      <mesh-id>D003287</mesh-id>
    </category>
    <category>
      <category>Electrolytes</category>
      <mesh-id>D004573</mesh-id>
    </category>
    <category>
      <category>Fluorides</category>
      <mesh-id>D005459</mesh-id>
    </category>
    <category>
      <category>Fluorine Compounds</category>
      <mesh-id>D017611</mesh-id>
    </category>
    <category>
      <category>Gases</category>
      <mesh-id>D005740</mesh-id>
    </category>
    <category>
      <category>Hydrofluoric Acid</category>
      <mesh-id>D006858</mesh-id>
    </category>
    <category>
      <category>Ions</category>
      <mesh-id>D007477</mesh-id>
    </category>
    <category>
      <category>Other Diagnostics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Sulfur Compounds</category>
      <mesh-id>D013457</mesh-id>
    </category>
    <category>
      <category>Ultrasound Contrast Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>Ultrasound Contrast Media</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form/>
      <route>Intravenous; Intravesical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route>Intravenous; Intravesical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, powder, for solution</form>
      <route>Intravenous</route>
      <strength>8 μl/ml</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="V08DA05">
      <level code="V08DA">Ultrasound contrast media</level>
      <level code="V08D">ULTRASOUND CONTRAST MEDIA</level>
      <level code="V08">CONTRAST MEDIA</level>
      <level code="V">VARIOUS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>36:89.00*</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <patents>
    <patent>
      <number>5686060</number>
      <country>United States</country>
      <approved>1997-11-11</approved>
      <expires>2017-11-11</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>10232061</number>
      <country>United States</country>
      <approved>2019-03-19</approved>
      <expires>2038-07-06</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
    <patent>
      <number>10335502</number>
      <country>United States</country>
      <approved>2019-07-02</approved>
      <expires>2038-07-06</expires>
      <pediatric-extension>false</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>2.28</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>hexafluoro-λ⁶-sulfane</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>sulfur hexafluoride</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>146.05</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>145.962490152</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>FS(F)(F)(F)(F)F</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>F6S</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/F6S/c1-7(2,3,4,5)6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>SFZCNBIFKDRMGX-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>18.44</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>7.11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>12131</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>30496</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>17358</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347827897</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D05962</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>16425</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Sulfur_hexafluoride</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1796998</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>